Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Michael A. Jarvis; Frederick A. Hansen; Kyle Rosenke; Elaine Haddock; Christopher Rollinson; Simon Rule; Graham Sewell; Andrew Hughes; Heinz Feldmann

doi:10.3851/imp3368

Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

Michael A. Jarvis^*, Frederick A. Hansen, Kyle Rosenke, Elaine Haddock, Christopher Rollinson, Simon Rule, Graham Sewell, Andrew Hughes, Heinz Feldmann

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Antiviral Therapy
Volume	0
Issue number	0
Early online date	3 Aug 2020
DOIs	https://doi.org/10.3851/imp3368
Publication status	Published - 3 Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3851/imp3368

Jarvis et al Antiviral Therapies Accepted Version

Cite this

@article{d211e15bf2a245eea4c00f4b2cdf9d91,

title = "Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system",

author = "Jarvis, {Michael A.} and Hansen, {Frederick A.} and Kyle Rosenke and Elaine Haddock and Christopher Rollinson and Simon Rule and Graham Sewell and Andrew Hughes and Heinz Feldmann",

year = "2020",

month = aug,

day = "3",

doi = "10.3851/imp3368",

language = "English",

volume = "0",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

number = "0",

}

TY - JOUR

T1 - Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system

AU - Jarvis, Michael A.

AU - Hansen, Frederick A.

AU - Rosenke, Kyle

AU - Haddock, Elaine

AU - Rollinson, Christopher

AU - Rule, Simon

AU - Sewell, Graham

AU - Hughes, Andrew

AU - Feldmann, Heinz

PY - 2020/8/3

Y1 - 2020/8/3

U2 - 10.3851/imp3368

DO - 10.3851/imp3368

M3 - Article

SN - 1359-6535

VL - 0

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 0

ER -